Indications of newer insulins include all EXCEPT:
**Core Concept**
The newer insulins, such as insulin glargine, insulin detemir, and insulin degludec, are long-acting basal insulin analogs designed to mimic the natural insulin profile. These insulins have a more stable and predictable action, reducing the risk of hypoglycemia and improving glycemic control in patients with diabetes mellitus.
**Why the Correct Answer is Right**
Newer insulins are indicated for the management of type 1 and type 2 diabetes mellitus, particularly in patients who require basal insulin therapy. They are also used in patients with insulin resistance, such as those with polycystic ovary syndrome (PCOS) or those taking glucocorticoids. The pharmacokinetic properties of newer insulins make them suitable for once-daily dosing, which can improve adherence and simplify insulin regimens.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while insulin analogs may be used in pregnant women with diabetes, this is not the primary indication for newer insulins.
**Option B:** Incorrect because while newer insulins may be used in patients with type 2 diabetes, this is not the primary indication for these insulins.
**Option C:** Incorrect because while newer insulins may be used in patients with insulin resistance, this is not the primary indication for these insulins.
**Clinical Pearl / High-Yield Fact**
Newer insulins are not interchangeable with regular insulin or NPH insulin, and their dosing should be individualized based on the patient's insulin needs and glucose profile.
**Correct Answer: D.**